Metachronous gallbladder metastasis from renal cell carcinoma-a rare clinical manifestation.
Renal cell carcinoma (RCC) represents a rare tumor entity accounting for approximately 3 % of all malignancies in the adult population. Approximately 30 % of all patients suffering from RCC develop metastases after nephrectomy and another 30 % of patients suffer from synchronous metastases at the date of diagnosis. Gallbladder metastases represent an extremely rare clinical condition and up to date there are only 35 published cases of gallbladder metastasis from RCC. Surgical resection should be the treatment of choice in any case based on the reported data in literature. In spite of the small series of cases, survival can be improved even in patients suffering from additional sites of metastases.
Department of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria. Karl.Mrak@Klinikum-Graz.At.
Karl
K
Mrak
Institute of Pathology, Medical University Of Graz, Graz, Austria.
Carolin
C
Lackner
Department of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
Hans-Jörg
HJ
Mischinger
Department of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
Peter
P
Kornprat
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000556:secondary* / Q000601:surgery*; D005706:Gallbladder Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000601:surgery*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000601:surgery*; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000601:surgery*; D035583:Rare Diseases / Q000175:diagnosis* / Q000601:surgery; D016896:Treatment Outcome
Gallbladder; Metachronous neoplasms; Neoplasm metastases; Renal cell carcinoma; Therapeutics